Efficacy of rocatinlimab for moderate-to-severe atopic dermatitis

被引：3
|
作者：
Devjani, Shivali [1 ]
Engel, Priya, V [2 ]
Javadi, Sogol S. [3 ]
Smith, Brandon [4 ]
Wu, Jashin J. [5 ]
机构：
[1] SUNY Downstate, Coll Med, New York, NY USA
[2] Calif Univ Sci & Med, Colton, CA USA
[3] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA USA
[4] Drexel Univ, Coll Med, Philadelphia, PA USA
[5] Univ Miami, Miller Sch Med, Dept Dermatol, Miami, FL 33136 USA
来源：
LANCET | 2023年 / 402卷 / 10415期
关键词：
D O I：
10.1016/S0140-6736(23)01619-7
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1833 / 1834
页数：2
相关论文
共 50 条
  • [21] Lebrikizumab for the Treatment of Moderate-to-Severe Atopic Dermatitis
    Bernardo, Diana
    Bieber, Thomas
    Torres, Tiago
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2023, 24 (05) : 753 - 764
  • [22] Dupilumab Efficacy and Safety in Adolescents with Moderate-to-Severe Atopic Dermatitis: A Case Series
    Mareschal, Adrien
    Puzenat, Eve
    Aubin, Francois
    ACTA DERMATO-VENEREOLOGICA, 2020, 100 (01)
  • [23] Integrated Efficacy and Safety Analysis of Abrocitinib in Adolescents With Moderate-to-Severe Atopic Dermatitis
    Paller, Amy S.
    Eichenfield, Lawrence F.
    Irvine, Alan D.
    Flohr, Carsten
    Wollenberg, Andreas
    Barbarot, Sebastien
    Bangert, Christine
    Spergel, Jonathan M.
    Selfridge, Andrew
    Biswas, Pinaki
    Fan, Haiyun
    Alderfer, Justine
    Watkins, Melissa
    Koppensteiner, Herwig
    ALLERGY, 2025,
  • [24] Efficacy and safety of abrocitinib in patients with moderate-to-severe atopic dermatitis and comorbid allergies
    Schmid-Grendelmeier, Peter
    Gooderham, Melinda J.
    Hartmann, Karin
    Konstantinou, George N.
    Fellmann, Marc
    Koulias, Christopher
    Clibborn, Claire
    Biswas, Pinaki
    Brunner, Patrick M.
    ALLERGY, 2024, 79 (01) : 174 - 183
  • [25] LONG-TERM EFFICACY OF TRALOKINUMAB IN ADOLESCENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS
    Wollenberg, Andreas
    Paller, Amy S.
    Bewley, Anthony
    Cork, Michael
    Hong, Chih-Ho
    Soong, Weily
    Oland, Christian Bjerregard
    Taveira, Christian Moreira
    Gjerum, Le
    Blauvelt, Andrew
    ACTA DERMATO-VENEREOLOGICA, 2023, 103 : 54 - 54
  • [26] Efficacy and safety of systemic treatments for moderate-to-severe atopic dermatitis: A systematic review
    Roekevisch, Evelien
    Spuls, Phyllis Ira
    Kuester, Denise
    Limpens, Jacqueline
    Schmitt, Jochen
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2014, 133 (02) : 429 - 438
  • [27] Efficacy and safety of upadacitinib in the treatment of moderate-to-severe atopic dermatitis: A systematic review
    Zhao, Dan-Jie
    Li, Xia
    Lin, Hai-Xia
    Zheng, Hong
    Zhou, Di
    Tang, Peng
    PLOS ONE, 2024, 19 (07):
  • [28] Efficacy and Safety of Upadacitinib in Moderate-to-Severe Atopic Dermatitis: A Meta-Analysis
    Meher, Bikash R.
    Mishra, Archana
    Behera, Biswanath
    Ponnusamy, Subashri
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (07)
  • [29] Patient Preferences in the Treatment of Moderate-to-severe Atopic Dermatitis
    Ameen, Mahreen
    Alhusaye, Raed
    Brandi, Henrik
    Bogelund, Mette
    Jensen, Henrik H.
    Reitzel, Signe B.
    Thyssen, Jacob P.
    ACTA DERMATO-VENEREOLOGICA, 2024, 104
  • [30] Abrocitinib: a potential treatment for moderate-to-severe atopic dermatitis
    Nezamololama, Novin
    Crowley, Erika L.
    Gooderham, Melinda J.
    Papp, Kim
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2020, 29 (09) : 911 - 917
12345